Cellbricks Therapeutics
Develops biofabricated human tissue implants and aims to manufacture 3D-printed organs
€10MSeed+Non-Dilutive
Role not disclosedLV
LifeX Ventures
Activity from announced rounds
Activity in this selectionMar 31, 2026 · Mar 1, 2026
LifeX Ventures is an AI and healthcare investment firm whose current portfolio includes Axo Longevity, Integral Privacy Technologies and Konko AI.
Recorded funding activity
Axo combines preventive-health testing with personalized insights. Konko develops patient-communication software, while Integral prepares data for AI use. The firm portfolio is distinct from its separately labeled previous personal investments and unrelated LifeX namesakes.
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $101.6M 2 disclosed · full round size, not this investor’s share